Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Blood Cell Count × Thoracic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Thoracic 1 Head & Neck 1 Breast 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 409 Cisplatin 337 Pemetrexed 266 Paclitaxel 266 Docetaxel 220 Erlotinib Hydrochloride 213 Gemcitabine 210 Radiotherapy 152 Bevacizumab 152 pembrolizumab 138 Nivolumab 113 Etoposide 96 Gefitinib 80 Vinorelbine 77 durvalumab 59 atezolizumab 58 Topotecan 58 Cetuximab 56 Drug Therapy 50 Irinotecan 49 Ipilimumab 45 Radiosurgery 44 Afatinib 43 osimertinib 42 Albumin-Bound Paclitaxel 34 130-nm albumin-bound paclitaxel 33 Cyclophosphamide 31 Surgical Procedures, Operative 30 Taxes 29 Surveys and Questionnaires 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03749512 2018-11-21

NLCR in Prediction of the Grade of Lung Tumor.

Medical University of Silesia

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡